CORRESP Filing
PLUS THERAPEUTICS, INC.
Date: June 17, 2025 · CIK: 0001095981 · Accession: 0001193125-25-142216
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Plus Therapeutics, Inc.
June 17, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549
Registration Statement on Form S-1 submitted for filing on June 17, 2025
File No. 333-
Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “ Securities Act ”), Plus Therapeutics, Inc. hereby requests for acceleration of the effective date of the above-referenced registration statement on Form S-1, as amended (the “ Registration Statement ”), so that it becomes effective as of 9:00 a.m. Eastern Time on Monday, June 23, 2025, or as soon thereafter as possible. [Signature Page to Follow]
Very truly yours,
Plus Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP June 17, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Plus Therapeutics, Inc. Registration Statement on Form S-1 submitted for filing on June 17, 2025 File No. 333- Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “ Securities Act ”), Plus Therapeutics, Inc. hereby requests for acceleration of the effective date of the above-referenced registration statement on Form S-1, as amended (the “ Registration Statement ”), so that it becomes effective as of 9:00 a.m. Eastern Time on Monday, June 23, 2025, or as soon thereafter as possible. [Signature Page to Follow] Very truly yours, Plus Therapeutics, Inc. By: /s/ Andrew Sims Name: Andrew Sims Title: Chief Financial Officer cc: Aaron M. Schleicher, Sullivan & Worcester LLP [Signature Page to Acceleration Request]